Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyBiologicalProcesspost-embryonic hemopoiesis

AHR JAK2

2.49e-057232GO:0035166
GeneOntologyCellularComponentdendritic spine head

SYNE1 FUS

1.38e-0416232GO:0044327
GeneOntologyCellularComponentperinuclear region of cytoplasm

HCN4 CERKL AKAP13 SYNE1 ABCA1 FUS

4.11e-04934236GO:0048471
HumanPhenoDelayed gross motor development

CDC40 EHMT1 SYNE1 DNASE2 RAB3GAP2 FUS GALNS

3.33e-05481127HP:0002194
DomainTyrKc

EPHA6 JAK2

5.21e-0388232SM00219
DomainTyr_kinase_cat_dom

EPHA6 JAK2

5.21e-0388232IPR020635
DomainPROTEIN_KINASE_TYR

EPHA6 JAK2

6.29e-0397232PS00109
DomainTyr_kinase_AS

EPHA6 JAK2

6.29e-0397232IPR008266
Pubmed

ABCA1 mutants reveal an interdependency between lipid export function, apoA-I binding activity, and Janus kinase 2 activation.

JAK2 ABCA1

1.25e-06323218776170
Pubmed

Aryl hydrocarbon receptor mediates Jak2/STAT3 signaling for non-small cell lung cancer stem cell maintenance.

AHR JAK2

1.25e-06323232941808
Pubmed

Association of common JAK2 variants with body fat, insulin sensitivity and lipid profile.

JAK2 ABCA1

1.25e-06323218239666
Pubmed

Interleukin-27 inhibits foam cell formation by promoting macrophage ABCA1 expression through JAK2/STAT3 pathway.

JAK2 ABCA1

2.51e-06423225194807
Pubmed

Molecular genetics of successful smoking cessation: convergent genome-wide association study results.

CERKL AKAP13 NRXN3

4.04e-0510123318519826
Pubmed

Genetic susceptibility to obesity and related traits in childhood and adolescence: influence of loci identified by genome-wide association studies.

KCTD15 NRXN3

4.99e-051623220724581
Pubmed

Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.

CDC40 HELZ AKAP13 SPAG5 CEMIP

5.72e-0565023538777146
Pubmed

Systematic analysis of human protein complexes identifies chromosome segregation proteins.

CDC40 EHMT1 SYNE1 ICAM1 SPAG5 FUS

8.22e-05115523620360068
Pubmed

Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.

EHMT1 KCTD15 AKAP13 DNASE2 FUS GALNS

1.55e-04129723633545068
Pubmed

Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.

EHMT1 SYNE1 RAB3GAP2

4.30e-0422523312168954
Pubmed

A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase.

HELZ AKAP13 FUS

4.70e-0423223325515538
CytobandEnsembl 112 genes in cytogenetic band chr15q25

AKAP13 CEMIP

2.91e-03160232chr15q25
CoexpressionHAY_BONE_MARROW_IMMATURE_NEUTROPHIL

AHR SLC43A2 ABCA1 ICAM1

2.35e-05195234M39200
CoexpressionZENG_GU_ICB_CONTROL_METAGENE_3_PRECICTIVE_ICB_RESPONSE

ABCA1 SPAG5 FUS CEMIP

3.21e-05211234MM17081
CoexpressionPARENT_MTOR_SIGNALING_UP

CDC40 JAK2 HELZ AKAP13 SYNE1

1.13e-04567235M16909
CoexpressionTRAVAGLINI_LUNG_EREG_DENDRITIC_CELL

AHR SLC43A2 AKAP13 ABCA1 ICAM1

1.23e-04577235M41697
CoexpressionBERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP

JAK2 HELZ

2.01e-0424232M16424
CoexpressionHARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_3DY_POSITIVE

CDC40 AHR ICAM1 GALNS

2.74e-04368234M41100
CoexpressionNAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_DN

AHR AKAP13 SYNE1 ICAM1

3.72e-04399234M40939
CoexpressionGSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_12H_DN

SLC43A2 SYNE1 ABCA1

3.75e-04162233M7002
CoexpressionGSE7348_UNSTIM_VS_LPS_STIM_MACROPHAGE_DN

AHR JAK2 ICAM1

4.31e-04170233M6846
CoexpressionGSE14415_FOXP3_KO_NATURAL_TREG_VS_TCONV_UP

EHMT1 SLC43A2 ABCA1

4.39e-04171233M2947
CoexpressionGSE37532_WT_VS_PPARG_KO_LN_TREG_UP

AHR HELZ ABCA1

4.77e-04176233M8952
CoexpressionIWANAGA_CARCINOGENESIS_BY_KRAS_UP

CDC40 SLC43A2 NRXN3

4.85e-04177233M9118
CoexpressionHAN_JNK_SINGALING_DN

AHR ABCA1

5.63e-0440232M1655
CoexpressionHARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_POSITIVE

CDC40 AHR JAK2 SLC43A2 ABCA1 ICAM1

5.82e-041250236M41099
CoexpressionJIANG_MELANOMA_TRM5_CD8

AKAP13 ICAM1 FUS

5.88e-04189233M48969
CoexpressionIWANAGA_CARCINOGENESIS_BY_KRAS_UP

CDC40 SLC43A2 NRXN3

6.15e-04192233MM752
CoexpressionHE_LIM_SUN_FETAL_LUNG_C1_AT1_CELL

ABCA1 ICAM1

6.21e-0442232M45688
CoexpressionGSE22886_TH1_VS_TH2_12H_ACT_DN

CDC40 JAK2 AKAP13

6.63e-04197233M4509
CoexpressionGSE12845_NAIVE_VS_DARKZONE_GC_TONSIL_BCELL_UP

JAK2 AKAP13 DNASE2

6.73e-04198233M3200
CoexpressionGSE3982_EOSINOPHIL_VS_EFF_MEMORY_CD4_TCELL_DN

EHMT1 DNASE2 RAB3GAP2

6.73e-04198233M5417
CoexpressionHAN_JNK_SINGALING_DN

AHR ABCA1

6.81e-0444232MM696
CoexpressionGSE17721_CTRL_VS_PAM3CSK4_4H_BMDC_DN

AHR FUS CEMIP

6.83e-04199233M3738
CoexpressionGSE31082_DP_VS_CD4_SP_THYMOCYTE_DN

JAK2 AKAP13 ICAM1

6.83e-04199233M5065
CoexpressionGSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_NK_CELL_UP

SYNE1 SPAG5 CEMIP

6.83e-04199233M9410
CoexpressionGSE46606_IRF4HIGH_VS_IRF4MID_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_DN

JAK2 ICAM1 SPAG5

6.83e-04199233M9846
CoexpressionGSE19401_NAIVE_VS_IMMUNIZED_MOUSE_PLN_FOLLICULAR_DC_UP

ICAM1 FUS CEMIP

6.83e-04199233M7656
CoexpressionGSE9006_TYPE_1_VS_TYPE_2_DIABETES_PBMC_AT_DX_DN

CDC40 RAB3GAP2 CEMIP

6.83e-04199233M5799
CoexpressionGSE42021_CD24INT_VS_CD24LOW_TCONV_THYMUS_UP

JAK2 CFHR2 ICAM1

6.83e-04199233M9596
CoexpressionGSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_DC_DN

HELZ SYNE1 DNASE2

6.83e-04199233M5201
CoexpressionGSE39152_BRAIN_VS_SPLEEN_CD103_NEG_MEMORY_CD8_TCELL_DN

AHR JAK2 ICAM1

6.93e-04200233M9071
CoexpressionGSE33424_CD161_HIGH_VS_NEG_CD8_TCELL_UP

EPHA6 ABCA1 ICAM1

6.93e-04200233M8541
CoexpressionGSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_6H_DN

SLC43A2 AKAP13 ABCA1

6.93e-04200233M6404
CoexpressionGSE14308_NAIVE_CD4_TCELL_VS_NATURAL_TREG_DN

RAB3GAP2 ICAM1 GALNS

6.93e-04200233M3394
CoexpressionGSE6875_TCONV_VS_FOXP3_KO_TREG_DN

CERKL SYNE1 RAB3GAP2

6.93e-04200233M6802
CoexpressionGSE9037_CTRL_VS_LPS_1H_STIM_BMDM_DN

JAK2 RAB3GAP2 FUS

6.93e-04200233M5801
CoexpressionGSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_DN

AHR AKAP13 ICAM1

6.93e-04200233M6247
CoexpressionGSE17721_0.5H_VS_4H_CPG_BMDC_DN

JAK2 ABCA1 ICAM1

6.93e-04200233M4125
CoexpressionGSE17721_0.5H_VS_24H_CPG_BMDC_DN

JAK2 SYNE1 ABCA1

6.93e-04200233M4129
CoexpressionGSE10240_CTRL_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN

EHMT1 DNASE2 SPAG5

6.93e-04200233M304
CoexpressionGSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_ADULT_UP

ABCA1 RAB3GAP2 ICAM1

6.93e-04200233M4561
CoexpressionGSE17721_PAM3CSK4_VS_GADIQUIMOD_24H_BMDC_UP

EPHA6 JAK2 HELZ

6.93e-04200233M3979
CoexpressionGSE40666_WT_VS_STAT1_KO_CD8_TCELL_DN

AHR SLC43A2 ICAM1

6.93e-04200233M9207
CoexpressionGSE40666_WT_VS_STAT4_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN

AHR SLC43A2 WFIKKN2

6.93e-04200233M9217
CoexpressionGSE21379_TFH_VS_NON_TFH_CD4_TCELL_DN

EPHA6 KCTD15 CERKL

6.93e-04200233M7508
CoexpressionGSE37301_RAG2_KO_VS_RAG2_AND_ETS1_KO_NK_CELL_UP

AHR CFHR2 ABCA1

6.93e-04200233M8844
CoexpressionGSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_UP

KCTD15 ICAM1 WFIKKN2

6.93e-04200233M6200
CoexpressionGSE43863_TH1_VS_TFH_MEMORY_CD4_TCELL_DN

JAK2 HELZ ABCA1

6.93e-04200233M9735
CoexpressionGSE7764_IL15_TREATED_VS_CTRL_NK_CELL_24H_DN

SYNE1 ABCA1 WFIKKN2

6.93e-04200233M5724
CoexpressionGSE25123_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_UP

EPHA6 AHR SPAG5

6.93e-04200233M7962
CoexpressionGSE42021_CD24HI_VS_CD24INT_TCONV_THYMUS_DN

JAK2 CFHR2 ICAM1

6.93e-04200233M9593
CoexpressionHALLMARK_INFLAMMATORY_RESPONSE

AHR ABCA1 ICAM1

6.93e-04200233M5932
CoexpressionGSE7831_CPG_VS_INFLUENZA_STIM_PDC_1H_DN

AHR JAK2 CFHR2

6.93e-04200233M6952
CoexpressionDAUER_STAT3_TARGETS_UP

ABCA1 ICAM1

8.11e-0448232M12391
CoexpressionHE_LIM_SUN_FETAL_LUNG_C7_FGFBP2_POS_NEURAL_PROGENITOR_CELL

DNASE2 WFIKKN2

9.51e-0452232M45792
CoexpressionOSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP

AKAP13 ICAM1 FUS

9.61e-04224233M12383
CoexpressionBUSSLINGER_DUODENAL_IMMUNE_CELLS

HELZ AKAP13 SYNE1 RAB3GAP2 FUS

1.00e-03911235M40038
CoexpressionSMIRNOV_RESPONSE_TO_IR_2HR_DN

JAK2 RAB3GAP2

1.14e-0357232M2586
CoexpressionXIE_TRASTUZUMAB_CARDIOTOXICITY_MMU_MIR_664_5P_GENES

EHMT1 GALNS

1.14e-0357232MM17505
ToppCellCOVID-19_Mild|World / Disease condition and Cell class

AHR SLC43A2 AKAP13 ICAM1 FUS

4.95e-0819823561ceb2245b6cb58e308b999a61d218c89dbc615e
ToppCellPBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

AHR SLC43A2 ABCA1 ICAM1

2.96e-06197234383d598ce3f8f5fc98bef3300e4cf7b6992aec9c
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

AHR SLC43A2 ABCA1 ICAM1

2.96e-061972340c8650bde08e1317baee4793201645d86f16e15d
ToppCellPBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

AHR SLC43A2 ABCA1 ICAM1

2.96e-061972343cc4e56a77f96a43f9b5a24cf1b9524c927ef795
ToppCellmild-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

AHR JAK2 SLC43A2 ICAM1

3.14e-06200234934c2efc780318c66d667ca75be0de350361d351
ToppCellmild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

JAK2 HELZ AKAP13 FUS

3.14e-0620023412f1685ce8f218433068e090c9d839cd5a1910bf
ToppCellSigmoid-Macrophage-Macrophage|Macrophage / Region, Cell class and subclass

AHR DNASE2 ABCA1

8.57e-05168233bb16e135b6ae0d66615420b61edd6f62f2a3233c
ToppCellCOVID-19_Severe-CD4+_CTL|World / disease group, cell group and cell class

SYNE1 NRXN3 CEMIP

8.72e-051692338c8168ac93a808d7b4756e4491db2b2979df1c1f
ToppCell390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

AHR KCTD15 SPAG5

9.84e-05176233437cfc5e06416bb0fc76d1f9dc106f74e279e880
ToppCellCOVID-19_Severe-CD4+_CTL|COVID-19_Severe / disease group, cell group and cell class

SYNE1 NRXN3 CEMIP

1.00e-0417723334e9455790bae905dd91923792f4109d18b7686e
ToppCellPBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

AHR SLC43A2 ICAM1

1.10e-04183233fcb0f755382d88fb207fc2322cd224c09c6e2ea6
ToppCellPBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

AHR SLC43A2 ICAM1

1.10e-041832334763df29c888d47c22076803b054f06b4cc29368
ToppCellILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

AHR AKAP13 FUS

1.18e-041872330099def970fbc828756fbf853eca2ce77b8cd342
ToppCellfacs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC43A2 AKAP13 ABCA1

1.20e-04188233a91443aa8fa8fa87f7501c59219daa0305bd0bbf
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_naive-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

AHR SLC43A2 AKAP13

1.21e-0418923355aba1ebc012006a5db3ff9c92589cb3d9f7c68a
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

SLC43A2 AKAP13 ABCA1

1.29e-041932335703a6faaee82cbad5ce73429bdf1b0f47b37ee0
ToppCellCOVID-19_Severe-Classical_Monocyte-cMono_4|COVID-19_Severe / Disease condition and Cell class

AHR ABCA1 ICAM1

1.33e-04195233787ea9f38ad8e2a836222ca97f4d927f7e79517d
ToppCell3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Myeloid-MMP9+_Inflammatory_macrophage|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract

DNASE2 ABCA1 ICAM1

1.33e-041952335a7c74f96f213c504abd65e751800da7e03e47d9
ToppCellnormal_Lung-Myeloid_cells-mo-Mac|normal_Lung / Location, Cell class and cell subclass

AHR ABCA1 ICAM1

1.35e-041962334d3a3264b3d781139899448cde3b7a4f214ca14d
ToppCell3'_v3-Lung-Myeloid_Mac-Intermediate_macrophages|Lung / Manually curated celltypes from each tissue

SLC43A2 ABCA1 ICAM1

1.37e-04197233bcb4dc17dae705bd84ea6a2842d6b107562baeb7
ToppCell3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

AKAP13 SYNE1 ICAM1

1.37e-04197233bf10727fbe90b71d2ac60a11711e5f0701b3799d
ToppCell10x5'v1-week_12-13-Myeloid_macrophage-stroma-stromal_macrophage|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

AHR DNASE2 ABCA1

1.37e-04197233075044c17f1c52008cd3c292c15cbf485b50411e
ToppCellmild_COVID-19-Classical_Monocyte|World / disease group, cell group and cell class (v2)

AHR SLC43A2 ICAM1

1.37e-041972335d826f4d7b7a46847c67e6bef38eb860bc808a6c
ToppCellNS-moderate-d_07-13-Myeloid-Non-resident_Macrophage|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

SLC43A2 ABCA1 ICAM1

1.37e-04197233774a5053f43ac7d614c127ae7363d32a3a194f63
ToppCellnormal_Lung-Myeloid_cells-mo-Mac|Myeloid_cells / Location, Cell class and cell subclass

AHR ABCA1 ICAM1

1.39e-04198233fbd72ebaba73cc30e79dc8a8c3d46b6f863c1494
ToppCellAT2_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id

AKAP13 SYNE1 ICAM1

1.39e-041982338a1f984e46f4fa5be33027b9dbaa2ca060a2245d
ToppCellsevere-HLA-DR+_CD83+_Monocyte|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

AHR SLC43A2 ICAM1

1.39e-04198233a77f3440d7fb6a50066abc7e9ad59e83798ef13d
ToppCell5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

AHR ABCA1 ICAM1

1.39e-04198233dbae6a58cb3ce8612755fbdba6194b70b35f258a
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

AHR SLC43A2 ABCA1

1.39e-04198233641e7be258303bb9782d19fcf8693f317581d3b8
ToppCellsevere-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

AHR SLC43A2 ICAM1

1.39e-04198233d5e525d2f2226d06a3fb985ce3a33555ff4b2e7b
ToppCellPBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

AHR SLC43A2 ICAM1

1.41e-0419923396dfbcf5261286f17d9718b04ebb7b288d229b52
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Monocytic-Classical_Monocyte-Mono_c2-CD14-HLA-DPB1|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)

AHR JAK2 SLC43A2

1.41e-041992334fc03377c017209111561789226621d258291481
ToppCellLPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

JAK2 SYNE1 ABCA1

1.41e-041992338b86c69aaf60feff53aa782559cfece7342a23de
ToppCellPBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

AHR SLC43A2 ICAM1

1.41e-0419923387d513a521dd0359f4f79b01e9e97eacb0a3c6e2
ToppCellPBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Monocytic-Classical_Monocyte-Mono_c2-CD14-HLA-DPB1|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)

AHR SLC43A2 ICAM1

1.41e-041992330e67257f1ecf90f80e6524d70d38b3733e953b4e
ToppCellcontrol-HLA-DR+_CD83+_Monocyte|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

AHR JAK2 SLC43A2

1.41e-04199233f1b370d2869ad29c9d8ff41fdcc486fffa781ee2
ToppCellmild-CD163+_Monocytes_(Sample_ID1_d7)|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

JAK2 SLC43A2 ABCA1

1.44e-0420023382126e25bfd8fba78dc1348fa5ad6a576289a139
ToppCellBrain_organoid-organoid_Tanaka_cellReport-1m-Neuronal-Interneuron|1m / Sample Type, Dataset, Time_group, and Cell type.

EPHA6 HCN4 NRXN3

1.44e-04200233fc839e9c33ea1d4ee0f42f21fd32a54e7cbe1f5a
ToppCellsaliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Classical_Monocyte-Mono_c1-CD14-CCL3|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

SLC43A2 ICAM1

1.75e-03121232b6dada0712b1f9793bc61e54ec7f10c9eaf53b86
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

KCTD15 RAB3GAP2

1.86e-0312523234d5be868c9728cc4f9ce0d65acf0e50171d2587
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell-T_gdT_c14-TRDV2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

KCTD15 RAB3GAP2

1.86e-03125232e112787b05d8147093357c9861877f6620b9e271
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Gpr149_Islr|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

AHR CEMIP

1.89e-031262323539a8fdbb52d191f36dce68c38798ad4d2b491a
ToppCellLPS_only-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

AKAP13 NRXN3

1.92e-031272325b0adbcafad31a6759c9bdce2f7f9591a8edc450
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

EPHA6 CERKL

1.95e-03128232003e133469899a9abe3a7f6d7f580583b281f412
ToppCellCOVID-19-kidney-Mito-rich_Int|kidney / Disease (COVID-19 only), tissue and cell type

HCN4 NRXN3

1.98e-0312923257b705106aec7bbfc587de1ccd4f2335fc44dd6f
ToppCell390C-Lymphocytic-NK_cells-NK_cell_B2|NK_cells / Donor, Lineage, Cell class and subclass (all cells)

JAK2 CEMIP

2.04e-0313123296d300958545714d18e905e860e95469c8ae4efa
ToppCell3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue

AKAP13 SYNE1

2.17e-03135232ae2d3a42e567b5bade304c0caa497eb725be3565
ToppCellILEUM-non-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

AKAP13 FUS

2.17e-03135232b7a792a7c0c22d8b703509f134115f0e394d7de0
ToppCell390C-Lymphocytic-NK_cells-NK_cell_B2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

JAK2 CEMIP

2.33e-03140232a88dbe7bf3e1419e360ab0b8cf24681d3424c3a7
ToppCellfrontal_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_ALM_Macc1_Lrg1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

CERKL SPAG5

2.40e-03142232d08e1880425d285c4433014fe0242ac7ff7734af
ToppCellTCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-2|TCGA-Thryoid / Sample_Type by Project: Shred V9

WFIKKN2 NRXN3

2.40e-03142232112f1b1bf7622e3bc1a2094c7710fab5a4083481
ToppCellControl-Classical_Monocyte-cMono_3|Control / Disease condition and Cell class

AHR ICAM1

2.43e-031432329d1cee36e32aefb6af5c65b3281b31a45d5cd17e
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)

KCTD15 NRXN3

2.53e-031462321e81ad3d6d5d5ad2f0176d2a9593a954d38fa294
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Calb1_Sst|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

ABCA1 CEMIP

2.53e-0314623210839a4fce2e62955a90592f927a6e0c6a84bbad
ToppCell10x5'-blood-Myeloid_Mac-Intermediate_macrophages|blood / Manually curated celltypes from each tissue

ABCA1 ICAM1

2.60e-03148232b801f38d249a02c4ceceb242cabbbc88418e5fd1
ToppCell10x5'-blood-Myeloid_Mac|blood / Manually curated celltypes from each tissue

ABCA1 ICAM1

2.60e-031482321ae2d7475e030e2de49940f3287b02953dbf3c65
ToppCellCerebellum-Endothelial-ENDOTHELIAL_TIP|Cerebellum / BrainAtlas - Mouse McCarroll V32

WFIKKN2 CEMIP

2.63e-031492323980fa4f1986a2f164a1826ea043fb71f1d756cd
ToppCellCiliated_cells-B-Donor_01|World / lung cells shred on cell class, cell subclass, sample id

HCN4 CERKL

2.63e-031492326399c5a2f06d79f020dece252526f1c0c110d569
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Akr1c18_Ntf3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

AHR CEMIP

2.63e-031492321e77f03d2b32f366018fec3462d1b75f6e7febb9
ToppCell(00)_Basal|World / shred by cell type and Timepoint

ABCA1 ICAM1

2.63e-0314923249e39206f37cee124ca4763c79425b805e50624b
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SLC43A2 NRXN3

2.67e-0315023287968ce885a4959616f0321f58517fe8029ba1b1
ToppCellPND01-03-samps-Epithelial-Alveolar_epithelial-AT1_-_meso|PND01-03-samps / Age Group, Lineage, Cell class and subclass

EPHA6 ICAM1

2.67e-031502326a13e4c4b9c9e54a5016573a37132465ec1c8f99
ToppCellLPS-antiTNF-Lymphocytic_NKT-T_cells-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

EPHA6 CEMIP

2.77e-03153232c4dcdcaa672929c1da870e9fb8ada1bb030ad12f
ToppCellnormal_Lymph_Node-Myeloid_cells-mo-Mac|Myeloid_cells / Location, Cell class and cell subclass

ABCA1 ICAM1

2.77e-031532325424494ea1f09542799045a875cc3eac13de5079
ToppCellfacs-Marrow-B-cells-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CFHR2 SYNE1

2.81e-0315423246155f36d3983f637b55d7525b675c8828f6ab2e
ToppCellfacs-Marrow-B-cells-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CFHR2 SYNE1

2.81e-0315423271ffc23a2e02e27cabbdbeaa622e59e9f4a4cd9d
ToppCellfacs-Pancreas-Exocrine-3m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

JAK2 ABCA1

2.85e-03155232441fcb6d05364fc6f4973f0b973f1a80b573ce1f
ToppCellprimary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_VISp_Adamts2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

EPHA6 SPAG5

2.88e-031562322cd007b423c2395c5ce331902e7f27c805755eb3
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-DC-cDC2-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

AHR AKAP13

2.88e-031562320f54d62c0fc08bbdd5ac743b2d5d748c3d1e6ef9
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

SLC43A2 NRXN3

2.92e-03157232c17c5c01fcb65c453690c265ec4f300ecdfefd34
ToppCellfacs-Pancreas-Exocrine-24m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DNASE2 SPAG5

2.92e-03157232370f44047ef438b8f1124c2c2761c150c0d8c57f
ToppCellfacs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

HCN4 CEMIP

2.92e-031572321f21d78a467fe22c5ab75d0917b840c1ac93f32c
ToppCellfacs-Trachea-nan-3m-Myeloid-lymphocyte_of_B_lineage|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CERKL SPAG5

2.92e-031572320fecc14959c4c9efc19d5c06475a890e0a30f148
ToppCellfacs-Brain_Myeloid-Striatum_-18m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

AHR SYNE1

2.92e-031572329d4308312301cb922f156a7b6aededc9e1c62807
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

AKAP13 SYNE1

2.95e-031582327274f020c0ecf216da4b6689c62bc5f49c29b6f3
ToppCellLPS_only-Myeloid-Monocytes,_Macrophages-T-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

EPHA6 CERKL

2.95e-0315823291d8c93af328c3bbebe1d8f019b94849ebc548c0
ToppCellCOVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type

EPHA6 NRXN3

2.99e-031592325335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

ABCA1 ICAM1

2.99e-03159232fb9a45c1d596226128ce4f1adaebb066766e590a
ToppCellLPS-antiTNF-Myeloid-Monocytes,_Macrophages-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

EPHA6 JAK2

3.03e-031602325d8d97c3da5837ba5fe743d2f8438f5cb7cea64b
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

AHR AKAP13

3.03e-031602326ed37d1fd0304932319d6b942502404115ff36a7
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SLC43A2 NRXN3

3.03e-031602321e210e526ea4d84fc58a798a26c0929bcb69fd89
ToppCellPND28-Immune-Immune_Myeloid-DC-cDC1-cDC1_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

JAK2 CFHR2

3.06e-0316123276c993a4533362db2250c88b3ee3ede55362d54e
ToppCellChildren_(3_yrs)-Epithelial-lung_goblet_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

AHR NRXN3

3.06e-031612322d63b279d9a5132e1c09b03930bf9039036d24a2
ToppCell5'-GW_trimst-2-LymphNode-Hematopoietic-T_cells-LTi-like_NCR+_ILC3|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

AHR HELZ

3.06e-03161232d59713ca84aa2acadfc9b3150d5f525e1b288860
ToppCellTCGA-Stomach-Solid_Tissue_Normal-Stomach_normal_tissue-Stomach_normal_tissue-7|TCGA-Stomach / Sample_Type by Project: Shred V9

EPHA6 WFIKKN2

3.10e-03162232b115b5799137122bd60696f8ae2aebadad6cd044
ToppCellE18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SLC43A2 DNASE2

3.14e-03163232d2fcd6f561748f7d29a051c504f016952ba32d0f
ToppCellPND28-Immune-Immune_Myeloid-DC-cDC1|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

JAK2 CFHR2

3.18e-031642325638d95c7cc5e59c4a7bda30268a904a01861a5f
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

EPHA6 SYNE1

3.22e-03165232e2aebb2fe197151e019371b8960f76f0c2386f08
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

EPHA6 SYNE1

3.22e-03165232b087771499aeb31cc4a338d2d0a9392a4ec1ac45
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

EPHA6 SYNE1

3.22e-03165232d8f8b088fd28a6b9dbd6b51bcaee42000e963321
ToppCellLV-16._Neuronal|World / Chamber and Cluster_Paper

AHR NRXN3

3.22e-031652326ed52cb756d21addf46c7f6c457458b01339fe04
ToppCellPND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte-Chondrocyte_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

KCTD15 CEMIP

3.25e-0316623237794a84601a2a949d579663d4a4bb8bc8fb5923
ToppCellPND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

KCTD15 CEMIP

3.25e-0316623281c546c6d847e49e662b81e71992ca0f7a99e890
ToppCellPBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Macrophage-macrophage,_alveolar|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)

EPHA6 AHR

3.25e-0316623228a44448a0b0d72459e8fe84ce5d666f16f514b3
ToppCellPBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Macrophage|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)

EPHA6 AHR

3.25e-031662322a04915d534a83e65aa168435d6856125b5bdd78
ToppCellCiliated_cells-B-Donor_08|World / lung cells shred on cell class, cell subclass, sample id

KCTD15 CERKL

3.25e-031662324b1056aad8a99827835242b8ab0c7f2bb84471f1
ToppCelldroplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC43A2 WFIKKN2

3.29e-03167232f5bffa77061baec0ba87bd688a047595f32534db
ToppCellPND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

KCTD15 CERKL

3.29e-03167232784776d1fcc098f84d3c2eca58fa56cb9428f434
ToppCelldroplet-Fat-Scat-18m-Myeloid-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC43A2 DNASE2

3.33e-03168232749eccebe4ee066f827d2a3980512f195f23ac27
ToppCell3'_v3-bone_marrow-Myeloid_Mac-Intermediate_macrophages|bone_marrow / Manually curated celltypes from each tissue

SLC43A2 ABCA1

3.33e-031682328ade4d098aeecda2d80c1cad1cebe9a063eae948
DrugEtilefrine hydrochloride [534-87-2]; Up 200; 18.4uM; PC3; HT_HG-U133A

JAK2 CFHR2 ABCA1 ICAM1 CEMIP

8.06e-071772354590_UP
Drugnickel chloride

AHR JAK2 KCTD15 HELZ SYNE1 DNASE2 ABCA1 ICAM1 SPAG5

1.09e-061178239ctd:C022838
Drug4-methoxyphenyl

AHR SYNE1 GALNS

1.18e-0621233CID000137580
DrugTolnaftate [2398-96-1]; Down 200; 13uM; PC3; HT_HG-U133A

CDC40 JAK2 ABCA1 ICAM1 FUS

1.27e-061942354221_DN
Drugdihydrosanguinarine

AHR SYNE1

5.85e-064232CID000124069
Drug2-hydroxypropyl-beta-cyclodextrin

AHR ABCA1

2.04e-057232ctd:C053839
DrugClenbuterol hydrochloride [21898-19-1]; Up 200; 12.8uM; PC3; HT_HG-U133A

AHR JAK2 ABCA1 CEMIP

2.27e-051682344671_UP
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A

AKAP13 SYNE1 ABCA1 NRXN3

2.55e-051732342105_UP
DrugAlexidine dihydrochloride [22573-93-9]; Up 200; 6.8uM; MCF7; HT_HG-U133A

JAK2 ICAM1 NRXN3 CEMIP

2.91e-051792344721_UP
Drug6-formylindolo(3,2-b)carbazole

AHR SYNE1 ICAM1

2.97e-0560233ctd:C111855
Drugtroglitazone; Down 200; 10uM; HL60; HT_HG-U133A

AKAP13 DNASE2 ABCA1 ICAM1

3.60e-051892342692_DN
Drugtrifluoroacetic acid

AHR SYNE1 GALNS

3.60e-0564233CID000006422
DrugBM-1

SYNE1 ICAM1 GALNS

3.95e-0566233CID000159986
DrugLidoflazine [3416-26-0]; Up 200; 8.2uM; MCF7; HT_HG-U133A

JAK2 HCN4 ICAM1 CEMIP

4.23e-051972343201_UP
DrugMeptazinol hydrochloride [59263-76-2]; Down 200; 14.8uM; PC3; HT_HG-U133A

DNASE2 RAB3GAP2 ICAM1 FUS

4.23e-051972344188_DN
DrugOrnidazole [16773-42-5]; Down 200; 18.2uM; MCF7; HT_HG-U133A

JAK2 ABCA1 ICAM1 FUS

4.32e-051982342272_DN
DrugCP-319743 [172078-87-4]; Down 200; 10uM; MCF7; HT_HG-U133A

EHMT1 JAK2 KCTD15 ABCA1

4.32e-051982347532_DN
Drugestradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A

JAK2 SYNE1 RAB3GAP2 ICAM1

4.32e-051982345905_UP
DrugBupropion hydrochloride [31677-93-7]; Up 200; 14.4uM; MCF7; HT_HG-U133A

EHMT1 CFHR2 RAB3GAP2 ICAM1

4.40e-051992346256_UP
Drug4-pyridinone

AHR SYNE1

5.34e-0511232CID000012290
Drug1-methylphenanthrene

AHR SPAG5

5.34e-0511232CID000013257
DrugC12063

AHR CERKL ICAM1 FUS GALNS

5.90e-05429235CID005282055
DrugPCB 180

AHR SPAG5

6.40e-0512232CID000037036
Drugperylene

AHR SPAG5

6.40e-0512232CID000009142
Drug3-hydroxyhexadecanoic acid

SPAG5 GALNS

7.56e-0513232CID000301590
Drug24,25-epoxycholesterol

ABCA1 ICAM1

7.56e-0513232ctd:C028358
DrugSpiro Compounds

JAK2 ICAM1

8.82e-0514232ctd:D013141
DrugCH2S

AHR SYNE1

1.16e-0416232CID000079115
DrugPCB 101

AHR SPAG5

1.16e-0416232CID000037807
DrugMethylthiouracil

JAK2 ICAM1

1.16e-0416232ctd:D008779
DrugPCB 118

AHR SPAG5

1.16e-0416232CID000035823
DrugPGDM

EHMT1 ICAM1

1.32e-0417232CID006441790
DrugRutin

AHR JAK2 ABCA1

1.58e-04105233ctd:D012431
Drugsexithiophene

SYNE1 SPAG5

1.65e-0419232CID011340899
Drugpolycyclic musk

AHR ABCA1

1.65e-0419232CID000006930
Drugscutellarin

ICAM1 FUS

1.83e-0420232CID000185617
Drugaminoflavone

AHR SYNE1

1.83e-0420232CID000389710
Drugcarnosol

AHR ICAM1

1.83e-0420232ctd:C068623
Drugdiosmin

AHR ICAM1

2.03e-0421232CID005281613
Drugmethacrylamide

ABCA1 GALNS

2.23e-0422232CID000006595
Drugbromotrimethyltin

AKAP13 DNASE2

2.66e-0424232CID000014015
Druglipoxin A4

AHR ICAM1

3.13e-0426232ctd:C040527
Drugbenzanthrone

AHR ICAM1

3.13e-0426232ctd:C012768
DrugGlutathione

AHR JAK2 ABCA1 ICAM1

3.46e-04340234ctd:D005978
Drugx1 00

SPAG5 GALNS

3.63e-0428232CID000019153
Drug5-Azachrysene

AHR SYNE1

3.63e-0428232CID000344234
DrugA-25

DNASE2 GALNS

3.63e-0428232CID003026721
Drug3 alpha,6 alpha-dihydroxy-5 beta-cholanoic acid

EHMT1 SYNE1

3.90e-0429232CID000006747
DrugPCB 28

AHR SPAG5

4.17e-0430232CID000023448
Drugherbimycin

AHR ICAM1

4.46e-0431232ctd:C020754
DrugAmplex Red reagent

AHR GALNS

4.46e-0431232CID000167453
Drugpalmitate

EHMT1 DNASE2 FUS GALNS

4.61e-04367234CID000000985
DrugMequindox

AHR JAK2

4.75e-0432232ctd:C545385
DrugIndican

AHR ICAM1

4.75e-0432232ctd:D007200
Drug1-anilino-4-methyl-2-methylthio-4-phenylimidazolin-5-one

ABCA1 ICAM1 NRXN3 CEMIP

4.90e-04373234ctd:C540355
DrugChelidonine monohydrate (+) [476-32-4]; Up 200; 10.8uM; HL60; HG-U133A

AHR AKAP13 ABCA1

4.96e-041552331786_UP
Drugthioridazine hydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A_EA

AHR ICAM1 CEMIP

5.05e-041562331010_UP
DrugGW 3965

ABCA1 ICAM1

5.06e-0433232ctd:C473027
DrugAC1Q6L57

AHR GALNS

5.37e-0434232CID000090740
DrugAC1OCACR

AKAP13 SYNE1

5.37e-0434232CID006914630
DrugBenzalkonium Compounds

ABCA1 ICAM1

5.37e-0434232ctd:D001548
Drugacteoside

AHR ICAM1

5.69e-0435232ctd:C058956
DrugRetinoic acid [302-79-4]; Up 200; 13.4uM; HL60; HG-U133A

AHR ABCA1 ICAM1

5.74e-041632331548_UP
Drugbut-2-enedioic acid dimethyl ester

AHR ICAM1

6.02e-0436232CID000012215
Drug6-thioguanosine

SYNE1 ABCA1

6.02e-0436232CID002724387
DrugTrichostatin A, Streptomyces sp.; Up 200; 1uM; PC3; HT_HG-U133A

AHR AKAP13 ABCA1

6.16e-041672331234_UP
Drug2,3',4,4',5-pentachlorobiphenyl

AHR ICAM1

6.36e-0437232ctd:C070055
Drug4-vinyl-1-cyclohexene dioxide

AHR ABCA1 FUS

6.49e-04170233ctd:C012606
DrugTea

AHR ABCA1

6.71e-0438232ctd:D013662
Drugiminomethanol

AKAP13 SYNE1

6.71e-0438232CID005460572
Drugprochlorperazine dimaleate salt; Up 200; 10uM; MCF7; HT_HG-U133A_EA

HCN4 ICAM1 CEMIP

6.83e-04173233995_UP
DrugEmodin

AHR JAK2 ICAM1

6.83e-04173233ctd:D004642
DrugC15H20O3

JAK2 ICAM1 FUS

7.06e-04175233CID000004692
DrugNSC325611

AKAP13 FUS

7.07e-0439232CID000003239
Drugoxybenzone

AHR SPAG5

7.07e-0439232CID000004632
Drugtrichostatin A, Streptomyces sp.; Up 200; 1uM; PC3; HT_HG-U133A

AHR AKAP13 NRXN3

7.18e-041762336546_UP
Drug(-)-Isoproterenol hydrochloride [5984-95-2]; Up 200; 16.2uM; PC3; HT_HG-U133A

JAK2 ABCA1 CEMIP

7.30e-041772334495_UP
DrugIvermectin [70288-86-7]; Up 200; 4.6uM; MCF7; HT_HG-U133A

HCN4 ICAM1 CEMIP

7.42e-041782332213_UP
Drugdn B

SYNE1 DNASE2

7.44e-0440232CID000008331
Drugdesflurane

ICAM1 GALNS

7.44e-0440232CID000042113
DrugSB216763

AHR JAK2

7.44e-0440232CID000176158
DrugRitodrine hydrochloride [23239-51-2]; Up 200; 12.4uM; PC3; HT_HG-U133A

JAK2 ABCA1 CEMIP

7.54e-041792334619_UP
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A

AKAP13 ABCA1 CEMIP

7.66e-041802333787_UP
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A

AHR AKAP13 NRXN3

7.66e-041802334344_UP
DrugDipivefrin hydrochloride [64019-93-8]; Up 200; 10.4uM; HL60; HG-U133A

AKAP13 ABCA1 GALNS

7.66e-041802331752_UP
DrugLynestrenol [52-76-6]; Up 200; 14uM; MCF7; HT_HG-U133A

JAK2 ICAM1 CEMIP

7.78e-041812331537_UP
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A

AHR AKAP13 ABCA1

7.78e-041812335822_UP
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A

AHR AKAP13 NRXN3

7.91e-041822336316_UP
DrugTiclopidine hydrochloride [53885-35-1]; Up 200; 13.4uM; MCF7; HT_HG-U133A

AKAP13 ICAM1 CEMIP

8.04e-041832331475_UP
DrugAC1Q6X9N

SPAG5 FUS

8.20e-0442232CID000072205
DrugRapamycin; Up 200; 0.1uM; PC3; HT_HG-U133A

HCN4 AKAP13 ABCA1

8.29e-041852334445_UP
DrugHexetidine [141-94-6]; Up 200; 11.8uM; HL60; HT_HG-U133A

JAK2 RAB3GAP2 ICAM1

8.29e-041852332457_UP
Drugvalinomycin; Up 200; 0.1uM; MCF7; HT_HG-U133A

EHMT1 JAK2 ICAM1

8.29e-041852335906_UP
DrugLY 294002; Up 200; 10uM; PC3; HT_HG-U133A

AKAP13 ABCA1 RAB3GAP2

8.42e-041862334463_UP
DrugMetoclopramide monohydrochloride [7232-21-5]; Down 200; 11.8uM; HL60; HT_HG-U133A

JAK2 KCTD15 FUS

8.42e-041862332353_DN
DrugCgp77675

AHR JAK2

8.60e-0443232CID005311381
Druglipopolysaccharide, Escherichia coli O111 B4

JAK2 ABCA1 ICAM1

8.69e-04188233ctd:C440499
DrugSB203580

AHR EHMT1 JAK2 AKAP13 ICAM1

8.90e-04771235CID000176155
DrugSulfamethoxazole [723-46-6]; Down 200; 15.8uM; MCF7; HT_HG-U133A

EHMT1 AKAP13 ICAM1

8.96e-041902332296_DN
DrugFenbendazole [43210-67-9]; Up 200; 13.4uM; MCF7; HT_HG-U133A

CFHR2 AKAP13 ICAM1

8.96e-041902333888_UP
DiseaseInflammation

AHR JAK2 ICAM1 GALNS

2.72e-06127234C0021368
DiseaseAtherogenesis

AHR ABCA1 ICAM1

1.31e-0559233C1563937
DiseaseAtherosclerosis

AHR ABCA1 ICAM1

1.31e-0559233C0004153
DiseaseEarly Pregnancy Loss

AHR JAK2 SPAG5

8.23e-05109233C3830362
DiseaseMiscarriage

AHR JAK2 SPAG5

8.23e-05109233C4552766
DiseaseSpontaneous abortion

AHR JAK2 SPAG5

8.23e-05109233C0000786
DiseaseAbortion, Tubal

AHR JAK2 SPAG5

8.23e-05109233C0000822
DiseaseBehcet Syndrome

AHR ICAM1

1.59e-0424232C0004943
Diseaseobesity (biomarker_via_orthology)

JAK2 ABCA1 ICAM1

1.99e-04147233DOID:9970 (biomarker_via_orthology)
DiseaseCrohn's disease (is_implicated_in)

JAK2 ICAM1

2.49e-0430232DOID:8778 (is_implicated_in)
Diseaseresponse to antidepressant

KCTD15 WFIKKN2 NRXN3

3.38e-04176233GO_0036276
DiseaseHypercholesterolemia

ABCA1 ICAM1

4.23e-0439232C0020443
DiseaseObesity

AHR KCTD15 ICAM1

5.28e-04205233C0028754

Protein segments in the cluster

PeptideGeneStartEntry
NECRNWQDNTAPMGN

AHR

491

P35869
NGNWTMQNPSPACQC

ABCA1

1451

O95477
QGPMTQAINRENWCT

AKAP13

1381

Q12802
DCNAVSTFWMANPNN

CEMIP

666

Q8WUJ3
IMTECWNNNVNQRPS

JAK2

1101

O60674
SACPNEGMEQQKLNW

OVOS1

736

Q6IE37
WQQMRTACIQSENNG

RAB3GAP2

821

Q9H2M9
PTCENMNFSWRNECN

FUS

431

P35637
NGWLSCQAQDEMLNL

SLC43A2

76

Q8N370
GNNQITCRNGQWSEP

CFHR2

186

P36980
DSCANQGVCMQQWEG

NRXN3

1056

Q9Y4C0
PENCQEWIGGKMAQN

HELZ

326

P42694
PDDCWVSINNMVNNS

HCN4

446

Q9Y3Q4
PAQPQLNVCNWAVMN

GALNS

481

P34059
WTCVGDMNRNQGEEQ

DNASE2

306

O00115
AQGSPKSDCNDQWQM

CERKL

406

Q49MI3
ENSQQTPMCQAWGNP

ICAM1

411

P05362
NGQMDVNCQDDGGWT

EHMT1

861

Q9H9B1
CNVMEPNQNNWLRTN

EPHA6

76

Q9UF33
QLDSNCQPMATNWIQ

SPAG5

1096

Q96R06
GWSNNCVPQMAENIS

SYNE1

2211

Q8NF91
PNGKWLACQSMDNQI

CDC40

471

O60508
MCNSVNAGWNQDPTH

KCTD15

201

Q96SI1
CPNDMNPNLWVDAQS

WFIKKN2

46

Q8TEU8